Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gb Sciences Inc (OP:GBLX)

0.0004 +0.0001 (+33.33%)
Streaming Delayed Price Updated: 11:16 AM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gb Sciences Inc

< Previous 1 2 Next >
Gb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus Treatment
Gb Sciences' collaboration with MSU has received media coverage across the country, starting with an interview from WLNS-TV in Lansing, Michigan, and interviews with Gb Sciences in the magazines... 
Via Newswire.com
Topics Cannabis
The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More
Below is a recap of the main news related to the cannabis industry and markets for the week of January 10, 2022. 
Via Benzinga
Gb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma Industry
Gb Sciences, Inc. (OTCQB:GBLX) announced Tuesday that it ha... 
Via Benzinga
Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility
The sale will accelerate the development of Gb Sciences' proprietary Parkinson's disease and COVID-related Cytokine-Release Syndrome therapies 
Via Newswire.com
Topics Cannabis
Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety
The biopharma technology company's AI-driven PhAROS™ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council... 
Via Newswire.com
Topics Artificial Intelligence Intellectual Property
Gb Sciences to Present at the SNN Network Summer Virtual Event on Wednesday, August 18th, 2021
LAS VEGAS, NV / ACCESSWIRE / August 10, 2021 / Gb Sciences (OTCQB:GBLX), a plant-based research and biopharmaceutical drug development company, today announced that it will be presenting at the SNN... 
From Gb Sciences
Via AccessWire
Topics Intellectual Property
GB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Proprietary AI-Accelerated Drug Discovery Platform
GB Sciences used PhAROS™, their novel AI-accelerated drug discovery platform, to identify and pre-validate optimized therapeutic mixtures for the treatment of anxiety, depression, and pain from... 
From GB Sciences, Inc.
Via AccessWire
Topics Animal Testing Artificial Intelligence Intellectual Property
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
GB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Proprietary AI-Accelerated Drug Discovery Platform
GB Sciences used PhAROS™, their novel AI-accelerated drug discovery platform, to identify and pre-validate optimized therapeutic mixtures for the treatment of anxiety, depression, and pain inspired by... 
Via Newswire.com
Topics Animal Testing Artificial Intelligence Intellectual Property
GB Sciences Using AI Technology in Plant-Based Drug Discovery Research
Biotech innovator GB Sciences has launched a drug discovery platform using AI technology that can identify and predict the efficacy of combinations of novel active ingredients from plants. 
Via Newswire.com
Topics Artificial Intelligence Cannabis Intellectual Property
GB Sciences Using AI Technology in Plant-Based Drug Discovery Research
Biotech innovator GB Sciences has launched a drug discovery platform using AI technology that can identify and predict the efficacy of combinations of novel active ingredients from plants. LAS VEGAS,... 
From GB Sciences, Inc.
Via AccessWire
Topics Artificial Intelligence Cannabis Intellectual Property
Gary Herman Joins GB Sciences' Subsidiary GbS Global Biopharma as Advisory Director
Herman will bring his experience as an investor in undervalued growth companies to this role as Advisory Director 
From GB Sciences
Via AccessWire
Topics Artificial Intelligence Cannabis Intellectual Property
Gary Herman Joins GB Sciences' Subsidiary GbS Global Biopharma as Advisory Director
Herman will bring his experience as an investor in undervalued growth companies to this role as Advisory Director 
Via Newswire.com
Topics Artificial Intelligence Cannabis Intellectual Property
GB Sciences' Board of Directors Has Passed a Unanimous Written Consent Promoting Dr. Andrea Small-Howard to the Role of President
The UWC also retains John Poss as Chairman and CEO of GB Sciences, Inc. LAS VEGAS, NV / ACCESSWIRE / June 17, 2021 / Dr. Andrea Small-Howard has been promoted to the role of President of GB Sciences,... 
From GB Sciences, Inc.
Via AccessWire
Topics Cannabis Intellectual Property
GB Sciences' Board of Directors Has Passed a Unanimous Written Consent Promoting Dr. Andrea Small-Howard to the Role of President
The UWC also retains John Poss as Chairman and CEO of GB Sciences, Inc. 
Via Newswire.com
Topics Cannabis Intellectual Property
Newswire's Guided Tour Client, GB Sciences, Builds Brand Awareness with Feature Article in Pharma's Almanac
GB Sciences, a client that's part of Newswire's Earned Media Advantage Guided Tour program, was recently featured in a Pharma's Almanac article discussing how the company has successfully incubated a... 
Via Newswire.com
Topics Cannabis Intellectual Property
GB Sciences Featured & Speaking at the SACHS Associates' 4th Annual Neuroscience Innovation Forum
Dr. Andrea Small-Howard will be speaking as a part of the live Pain, Migraine & Addiction Panel on April 29 at 11:50 a.m. EDT, and she will be presenting the company during the 20-minute SPOTLIGHT... 
Via Newswire.com
Topics Intellectual Property
GB Sciences Featured & Speaking at the SACHS Associates' 4th Annual Neuroscience Innovation Forum
Dr. Andrea Small-Howard will be speaking as a part of the live Pain, Migraine & Addiction Panel on April 29 at 11:50 a.m. EDT, and she will be presenting the company during the 20-minute SPOTLIGHT... 
From GB Sciences
Via AccessWire
Topics Intellectual Property
GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals
Purisys will supply ultra-high purity cannabinoids for use in GB Sciences' cannabinoid-containing, optimized therapeutic mixtures (OTM). 
Via Newswire.com
Topics Cannabis Intellectual Property Supply Chain
GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals
Purisys will supply ultra-high purity cannabinoids for use in GB Sciences' cannabinoid-containing, optimized therapeutic mixtures (OTM). LAS VEGAS, NV / ACCESSWIRE / April 20, 2021 / GB Sciences, Inc.... 
From GB Sciences, Inc.
Via AccessWire
Topics Cannabis Intellectual Property Supply Chain
GB Sciences Joins Newswire's Guided Tour Program to Showcase Its Capabilities as a Phytomedicine Company
GB Sciences, a phytomedicine research and biopharmaceutical drug development company, recently joined Newswire's Earned Media Advantage Guided Tour program. 
Via Newswire.com
Topics Cannabis
GB Sciences Files Provisional Patent Application to Protect Its Proprietary Drug Discovery Platform
GBS' newest proprietary drug discovery platform uses data analytics and machine learning to gain valuable predictive insights into the likely efficacy of novel plant-derived therapeutics. This unique... 
Via Newswire.com
Topics Artificial Intelligence Intellectual Property
GB Sciences Files Provisional Patent Application to Protect Its Proprietary Drug Discovery Platform
GBS' newest proprietary drug discovery platform uses data analytics and machine learning to gain valuable predictive insights into the likely efficacy of novel plant-derived therapeutics. This unique... 
From GB Sciences, Inc.
Via AccessWire
Topics Artificial Intelligence Intellectual Property
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.